Histopathology of hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is currently the sixth most common type of cancer with a high mortality rate and an increasing incidence worldwide. Its etiology is usually linked to environmental, dietary or life-style factors. HCC most commonly arises in a cirrhotic liver but interestingly an increasing proportion of HCCs develop in the non-fibrotic or minimal fibrotic liver and a shift in the underlying etiology can be observed. Although this process is yet to be completely understood, this changing scenario also has impact on the material seen by pathologists, presenting them with new diagnostic dilemmas. Histopathologic criteria for diagnosing classical, progressed HCC are well established and known, but with an increase in detection of small and early HCCs due to routine screening programs, the diagnosis of these small lesions in core needle biopsies poses a difficult challenge. These lesions can be far more difficult to distinguish from one another than progressed HCC, which is usually a clear cut hematoxylin and eosin diagnosis. Furthermore lesions thought to derive from progenitor cells have recently been reclassified in the WHO. This review summarizes recent developments and tries to put new HCC biomarkers in context with the WHOs reclassification. Furthermore it also addresses the group of tumors known as combined hepatocellular-cholangiocellular carcinomas.

[1]  V. Paradis,et al.  Histopathology of hepatocellular carcinoma. , 2013, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[2]  S. Thung,et al.  Changing Epidemiology of Hepatocellular Adenoma in the United States: Review of the Literature , 2013, International journal of hepatology.

[3]  B. le Bail,et al.  Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. , 1997, Journal of hepatology.

[4]  S. Kakar,et al.  Diagnosis of Well-differentiated Hepatocellular Lesions: Role of Immunohistochemistry and Other Ancillary Techniques , 2011, Advances in anatomic pathology.

[5]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[6]  H. Bismuth,et al.  Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation , 2000, Histopathology.

[7]  M. Makuuchi,et al.  Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. , 1989, The American journal of surgical pathology.

[8]  S. Kakar,et al.  Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum , 2008, Modern Pathology.

[9]  V. Desmet,et al.  Abundant expression of cytokeratin 7 in fibrolamellar carcinoma of the liver , 1990, Histopathology.

[10]  M. Colombo,et al.  Liver precancerous lesions and hepatocellular carcinoma: the histology report. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[11]  K. Tanikawa,et al.  The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound‐guided fine‐needle biopsy with those of autopsy , 1992, Cancer.

[12]  S. Hirohashi,et al.  Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules. , 2005, Journal of hepatology.

[13]  F. Kondo,et al.  Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules , 2007, Cancer.

[14]  J. Zucman‐Rossi,et al.  Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC , 2006, Hepatology.

[15]  T. Terada Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype. , 2013, International journal of clinical and experimental pathology.

[16]  R. Sormunen,et al.  Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma , 1998, Histopathology.

[17]  M. Omata,et al.  Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico‐pathologic features , 1980, Cancer.

[18]  S. Hattori,et al.  Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification , 2013, The American journal of surgical pathology.

[19]  A. Huvos,et al.  Clear-cell carcinoma of the liver. A clinicopathologic study of 13 patients. , 1974, American journal of clinical pathology.

[20]  Michiie Sakamoto,et al.  Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia , 2009, Hepatology.

[21]  Yi-jun Wang,et al.  Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm. , 2012, American journal of clinical pathology.

[22]  S. Fan,et al.  Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis , 2003, The Journal of pathology.

[23]  T. Takada,et al.  Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma , 2011, Journal of hepato-biliary-pancreatic sciences.

[24]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[25]  Michael A. Choti,et al.  Preoperative Assessment of Hepatocellular Carcinoma Tumor Grade Using Needle Biopsy: Implications for Transplant Eligibility , 2007, Annals of surgery.

[26]  T. Roskams,et al.  Glypican-3 Expression Distinguishes Small Hepatocellular Carcinomas From Cirrhosis, Dysplastic Nodules, and Focal Nodular Hyperplasia-like Nodules , 2006, The American journal of surgical pathology.

[27]  S. Hirohashi,et al.  Hyperplastic foci reflect the risk of multicentric development of human hepatocellular carcinoma. , 1998, Journal of hepatology.

[28]  P. Schirmacher,et al.  Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification , 2013, International journal of hepatology.

[29]  M. Matsuda,et al.  β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection , 1999 .

[30]  A. Roessner,et al.  Canalicular Immunostaining of Neprilysin (CD10) as a Diagnostic Marker for Hepatocellular Carcinomas , 2001, The American journal of surgical pathology.

[31]  O. Nakashima,et al.  Pathology of early hepatocellular carcinoma: progression from early to advanced. , 1996, Seminars in surgical oncology.

[32]  L. Blumgart,et al.  Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. , 1986, American journal of surgery.

[33]  M. Kojiro,et al.  Clinicopathologic study on clear cell hepatocellular carcinoma , 1996, Pathology international.

[34]  K. Jang,et al.  Hepatocellular carcinoma with massive lymphoid infiltration: a regressing phenomenon? , 2009, Pathology, research and practice.

[35]  M. Roncalli Hepatocellular nodules in cirrhosis: Focus on diagnostic criteria on liver biopsy. A Western experience , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  S. Hirohashi,et al.  p53 gene mutation spectrum in hepatocellular carcinoma. , 1992, Cancer research.

[37]  K. Sugimachi,et al.  Sarcomatous hepatocellular carcinoma: A special reference to ordinary hepatocellular carcinoma 1 , 2003, Journal of gastroenterology and hepatology.

[38]  Hiroyuki Aburatani,et al.  The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma , 2005, Modern Pathology.

[39]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[40]  L. Laurino,et al.  Relationship between cirrhosis, liver cancer, and hepatic metastases. An autopsy study , 1989, Cancer.

[41]  M. Kojiro,et al.  Hepatocellular carcinoma with sarcomatous change. , 1997, Oncology reports.

[42]  H. El‐Serag,et al.  Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population‐based study , 2004, Hepatology.

[43]  S. Kakar,et al.  Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas. , 2013, Human pathology.

[44]  A. West,et al.  Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers , 2004, Hepatology.

[45]  M. Kage,et al.  Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to small hepatocellular carcinoma with indistinct margins , 1995, Hepatology.

[46]  M. Kojiro,et al.  Vascularization of small hepatocellular carcinomas: correlation with differentiation. , 1999, Liver.

[47]  S. Hirohashi,et al.  Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. , 1991, Human pathology.

[48]  S. Sell,et al.  The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. , 1993, The International journal of developmental biology.

[49]  M. Anzola Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis , 2004, Journal of Viral Hepatitis.

[50]  S. Kakar,et al.  Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. , 2003, American journal of clinical pathology.

[51]  P. Pineau,et al.  Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases , 2000, Hepatology.

[52]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[53]  M. Colombo,et al.  Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma , 2011, Hepatology.

[54]  S. Hirohashi,et al.  Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. , 1992, Cancer research.

[55]  V. Paradis,et al.  Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. , 2006, Human pathology.

[56]  J. Emond,et al.  Steatohepatitic Hepatocellular Carcinoma (SH-HCC): A Distinctive Histological Variant of HCC in Hepatitis C Virus-related Cirrhosis With Associated NAFLD/NASH , 2010, The American journal of surgical pathology.

[57]  G. Kaygusuz,et al.  The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma. , 2010, Pathology, research and practice.

[58]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[59]  A. West,et al.  Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. , 2003, Journal of hepatology.

[60]  Y. Asayama,et al.  ‘Scirrhous’ type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1 , 2005, Histopathology.

[61]  K. Okita,et al.  Morphologic studies of the liver cell dysplasia , 1983, Cancer.

[62]  J. Haratake,et al.  Investigation of resected multinodular hepatocellular carcinoma: assessment of unicentric or multicentric genesis from histological and prognostic viewpoint. , 1994, The American journal of gastroenterology.

[63]  Y. N. Park,et al.  The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. , 2009, Journal of hepatology.

[64]  L. Terracciano,et al.  Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis , 2007, Hepatology.

[65]  V. Paradis,et al.  Changing trends in malignant transformation of hepatocellular adenoma , 2010, Gut.

[66]  M. Matsuda,et al.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin , 2007, Hepatology.